Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vials

Eli Lilly is slashing prices for certain doses of its weight loss drug Zepbound, selling single-dose vials at much cheaper prices for people who pay out of pocket. Dr. Timothy Mackey, professor in the Global Health Program at the University of California, San Diego, joined Business City News to discuss the price cuts.